West Pharmaceutical Services (WST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 593,400 | 585,900 | 661,800 | 346,200 | 241,700 |
| Depreciation Amortization | 137,300 | 120,600 | 122,300 | 109,100 | 103,400 |
| Income taxes - deferred | 37,500 | -30,800 | -42,900 | -5,800 | 15,300 |
| Accounts receivable | 4,000 | -35,600 | -123,500 | -46,600 | -33,300 |
| Accounts payable and accrued liabilities | 4,400 | -2,800 | 16,800 | 36,600 | 25,300 |
| Other Working Capital | -20,400 | -15,000 | -198,100 | -10,300 | -14,400 |
| Other Operating Activity | 20,300 | 101,700 | 147,600 | 43,300 | 29,200 |
| Operating Cash Flow | $776,500 | $724,000 | $584,000 | $472,500 | $367,200 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -362,000 | -284,600 | -253,400 | -174,400 | -126,400 |
| Net Acquisitions | N/A | N/A | -2,200 | N/A | -18,900 |
| Purchase Of Investment | N/A | N/A | N/A | N/A | -85,100 |
| Other Investing Activity | -6,700 | -3,600 | 2,500 | -5,100 | 2,400 |
| Investing Cash Flow | $-368,700 | $-288,200 | $-253,100 | $-179,500 | $-228,000 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | N/A | 198,500 |
| Debt Repayment | -2,300 | -44,300 | -2,200 | -2,300 | -136,400 |
| Common Stock Issued | 51,000 | 28,200 | 37,100 | 34,700 | 32,700 |
| Common Stock Repurchased | -451,200 | -222,200 | -151,900 | -121,400 | -85,300 |
| Dividend Paid | -57,000 | -54,100 | -51,100 | -48,100 | -45,100 |
| Other Financing Activity | -100 | -1,200 | 0 | 0 | -1,200 |
| Financing Cash Flow | $-459,600 | $-293,600 | $-168,100 | $-137,100 | $-36,800 |
| Exchange Rate Effect | 11,400 | -10,500 | -15,700 | 20,500 | -700 |
| Beginning Cash Position | 894,300 | 762,600 | 615,500 | 439,100 | 337,400 |
| End Cash Position | 853,900 | 894,300 | 762,600 | 615,500 | 439,100 |
| Net Cash Flow | $-40,400 | $131,700 | $147,100 | $176,400 | $101,700 |
| Free Cash Flow | |||||
| Operating Cash Flow | 776,500 | 724,000 | 584,000 | 472,500 | 367,200 |
| Capital Expenditure | -362,000 | -284,600 | -253,400 | -174,400 | -126,400 |
| Free Cash Flow | 414,500 | 439,400 | 330,600 | 298,100 | 240,800 |